Timken Company (TKR) Q3 2024 earnings summary

Executive summary

• Third quarter 2024 sales were $1.13 billion, down 1.4% year-over-year, with organic sales down 2.9% due to lower volumes in Europe and China, partially offset by growth in the Americas, India, and acquisitions.

• Adjusted EBITDA margin was 16.9%, down from 18.9% last year, and adjusted EPS was $1.23, a 21% decrease, both below expectations due to lower volumes and higher logistics costs.

• Net income for Q3 2024 was $81.8 million ($1.16 per diluted share), down 6.9% year-over-year.

• Free cash flow for the quarter was $88 million, with net debt to adjusted EBITDA at 2.1x.

• Recent acquisitions, including CGI, expanded presence in automation and medical robotics; CEO transition announced with Tarak Mehta appointed in September 2024.

Financial highlights

• Adjusted EBITDA was $190 million (16.9% margin), down from $216 million (18.9%) last year.

• Adjusted EPS was $1.23, down from $1.55 in Q3 2023; net income margin was 7.3%.

• Free cash flow for Q3 was $88 million after $35 million in CapEx; full-year free cash flow outlook reduced to ~$300 million.

• Net debt at quarter-end was $1.83 billion, with no significant maturities until 2027.

• Paid 409th consecutive quarterly dividend in Q3 2024.

Outlook and guidance

• Full-year 2024 revenue expected to decline ~4% versus 2023, with organic sales down ~6% at midpoint.

• Adjusted EPS guidance lowered to $5.55–$5.65; full-year adjusted EBITDA margin expected in the low 18% range.

• Free cash flow outlook reduced to ~$300 million, with strong Q4 FCF expected (> $100 million).

• Fourth quarter margins and EPS expected to be down sequentially and year-over-year due to lower production and higher costs.

• Cost reduction actions to be detailed in early 2025, targeting improved margins and profitability.